| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 191.67B | 187.05B | 177.35B | 171.94B | 138.55B | 109.25B |
| Gross Profit | 24.98B | 25.38B | 26.26B | 20.98B | 18.03B | 14.56B |
| EBITDA | 16.10B | 16.45B | 18.55B | 17.18B | 15.98B | 15.78B |
| Net Income | 5.82B | 5.96B | 5.68B | 5.23B | 23.02B | 6.06B |
Balance Sheet | ||||||
| Total Assets | 140.82B | 143.39B | 143.52B | 138.89B | 132.58B | 154.99B |
| Cash, Cash Equivalents and Short-Term Investments | 42.88B | 45.09B | 45.59B | 39.48B | 28.49B | 16.27B |
| Total Debt | 20.43B | 24.28B | 25.20B | 25.85B | 25.18B | 28.34B |
| Total Liabilities | 49.76B | 54.55B | 57.74B | 58.19B | 56.72B | 70.46B |
| Stockholders Equity | 66.99B | 65.15B | 63.45B | 59.91B | 56.27B | 53.58B |
Cash Flow | ||||||
| Free Cash Flow | 6.31B | 6.42B | 9.23B | 9.15B | 4.14B | 9.94B |
| Operating Cash Flow | 11.55B | 12.51B | 14.41B | 14.87B | 12.00B | 16.74B |
| Investing Cash Flow | 440.00M | -3.49B | -1.06B | -18.45B | 25.60B | -8.83B |
| Financing Cash Flow | -12.03B | -8.59B | -6.04B | -4.92B | -25.72B | -9.81B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$940.22M | 10.11 | 4.05% | ― | -12.48% | ― | |
71 Outperform | HK$62.86B | 11.10 | 7.88% | 4.58% | 4.37% | 0.58% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
55 Neutral | HK$185.46M | -5.13 | -22.12% | ― | -29.86% | -791.02% | |
46 Neutral | HK$124.37M | -0.26 | 167.07% | ― | -76.52% | -630.18% | |
45 Neutral | HK$28.10B | -8.27 | -5.96% | 1.65% | -11.11% | 62.07% | |
40 Underperform | HK$1.28B | -2.41 | 153.66% | ― | -14.95% | -932.70% |